Request for Covid-19 Impact Assessment of this Report

Take Action
Medical Devices

Global Breast Cancer Diagnostics Market Size study, by Diagnostic Type (Ionizing breast imaging technologies, Non-ionizing imaging technologies), by End-User (Hospitals, Cancer Research centers/institutes, Diagnostic Clinical Laboratories, Ambulatory Surgical centers) and Regional Forecasts 2020-2026

  • BIZ3834159
  • 200 Pages
  • April 2020
  • Medical Devices
Download Sample    Get Discount   
 
Global Breast Cancer Diagnostics Market is valued approximately USD 5.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2020-2026. Breast cancer is a malignant tumor formed in the breast cells that can spread into the whole parts of the body. It is diagnosed with the use of several tests to locate the site of initiation and the spread of the tumor to several parts of the body. At the initial stage, it can be diagnosed through certain screening tests such as yearly mammograms, MRI and CT scan. Increasing incidence of breast cancer among women, growing number of approvals for breast cancer diagnosis technologies, and favorable reimbursement framework for breast cancer diagnosis are the few factors responsible for high CAGR of the market over the forecast period. According to the World Cancer Research Fund International (WCRFI), breast cancer is the most common form of cancer in women worldwide with an average 2million new cases being detected every year. American Cancer Research Society (ACRS) anticipates by 2030, that incident rate of breast cancer is expected to reach over 9.9 million cases with over 5.5 million annual deaths, primarily due to aging population. Similarly, as per the European Breast Cancer Coalition, incidence in the EU-28 in 2018 was estimated to be around 404,920. This, in turn, is anticipated to accelerate the demand of breast cancer diagnostics around the world. However, high installation cost of devices and side effects of radiation are the few factors expected to impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Breast Cancer Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high patient awareness, well-established diagnostic infrastructure, and the early adoption of technologically advanced imaging systems in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rising incidence of breast cancer and rapidly improving healthcare infrastructure in the countries like China and India.

Major market player included in this report are:

Hologic Inc.

GE Healthcare

Phillips Healthcare

Fujifilm Holdings Corporation

Gamma Medica Inc.

Toshiba Corporation

Aurora Imaging Technology Inc.

Dilion Technologies Inc.

Genomic Health

NanoString Technologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnostic Type:

Ionizing breast imaging technologies

Non-ionizing imaging technologies

By End-User:

Hospitals

Cancer research centers/institutes

Diagnostic Clinical laboratories

Ambulatory Surgical centers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global Breast Cancer Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)

1.2.1. Breast Cancer Diagnostics Market, by Region, 2018-2026 (USD Billion)

1.2.2. Breast Cancer Diagnostics Market, by Diagnostic Type, 2018-2026 (USD Billion)

1.2.3. Breast Cancer Diagnostics Market, by End-User, 2018-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Breast Cancer Diagnostics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Breast Cancer Diagnostics Market Dynamics

3.1. Breast Cancer Diagnostics Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Breast Cancer Diagnostics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Breast Cancer Diagnostics Market, by Diagnostic Type

5.1. Market Snapshot

5.2. Global Breast Cancer Diagnostics Market by Diagnostic Type, Performance - Potential Analysis

5.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by Diagnostic Type 2016-2026 (USD Billion)

5.4. Breast Cancer Diagnostics Market, Sub Segment Analysis

5.4.1. Ionizing breast imaging technologies

5.4.2. Non-ionizing imaging technologies

Chapter 6. Global Breast Cancer Diagnostics Market, by End-User

6.1. Market Snapshot

6.2. Global Breast Cancer Diagnostics Market by End-User, Performance - Potential Analysis

6.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)

6.4. Breast Cancer Diagnostics Market, Sub Segment Analysis

6.4.1. Hospitals

6.4.2. Cancer research centers/institutes

6.4.3. Diagnostic Clinical laboratories

6.4.4. Ambulatory Surgical centers

Chapter 7. Global Breast Cancer Diagnostics Market, Regional Analysis

7.1. Breast Cancer Diagnostics Market, Regional Market Snapshot

7.2. North America Breast Cancer Diagnostics Market

7.2.1. U.S. Breast Cancer Diagnostics Market

7.2.1.1. Diagnostic Type breakdown estimates & forecasts, 2016-2026

7.2.1.2. End-User breakdown estimates & forecasts, 2016-2026

7.2.2. Canada Breast Cancer Diagnostics Market

7.3. Europe Breast Cancer Diagnostics Market Snapshot

7.3.1. U.K. Breast Cancer Diagnostics Market

7.3.2. Germany Breast Cancer Diagnostics Market

7.3.3. Rest of Europe Breast Cancer Diagnostics Market

7.4. Asia-Pacific Breast Cancer Diagnostics Market Snapshot

7.4.1. China Breast Cancer Diagnostics Market

7.4.2. India Breast Cancer Diagnostics Market

7.4.3. Japan Breast Cancer Diagnostics Market

7.4.4. Rest of Asia Pacific Breast Cancer Diagnostics Market

7.5. Latin America Breast Cancer Diagnostics Market Snapshot

7.5.1. Brazil Breast Cancer Diagnostics Market

7.5.2. Mexico Breast Cancer Diagnostics Market

7.6. Rest of The World Breast Cancer Diagnostics Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Hologic Inc.

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. GE Healthcare

8.2.3. Phillips Healthcare

8.2.4. Fujifilm Holdings Corporation

8.2.5. Gamma Medica Inc.

8.2.6. Toshiba Corporation

8.2.7. Aurora Imaging Technology Inc.

8.2.8. Dilion Technologies Inc.

8.2.9. Genomic Health

8.2.10. NanoString Technologies, Inc.

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER DIAGNOSTICS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER DIAGNOSTICS MARKET

TABLE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY DIAGNOSTIC TYPE 2016-2026 (USD BILLION)

TABLE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)

TABLE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 21. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 22. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 23. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 24. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 25. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 26. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 27. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 28. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 29. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 30. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 31. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 32. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 33. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 35. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 36. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 38. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 39. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 41. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 42. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 43. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 44. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 45. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 47. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 48. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 50. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 51. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 53. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 54. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 56. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 57. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
View Details
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research